Renaissance Capital LLC Ab Cellera Biologics Inc. Transaction History

Renaissance Capital LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 11, 2023	SELL	$7.31 - $11.18 $7,448 - $11,392	-1,019 Reduced 11.35%	7,957 $59,000
Q4 2022 Jan 06, 2023	BUY	$9.48 - $14.52 $85,092 - $130,331	8,976 New	8,976 $0
Q1 2022 May 12, 2022	SELL	$7.46 - $14.14 $77,039 - $146,023	-10,327 Closed	0 $0
Q4 2021 Feb 01, 2022	SELL	$12.99 - $17.73 $23,576 - $32,179	-1,815 Reduced 14.95%	10,327 $148,000
Q3 2021 Feb 01, 2022	SELL	$14.85 - $21.34 $242,782 - $348,887	-16,349 Reduced 57.38%	12,142 $243,000
Q2 2021 Feb 01, 2022	SELL	$20.19 - $34.17 $126,591 - $214,245	-6,270 Reduced 18.04%	28,491 $627,000
Q1 2021 Feb 01, 2022	BUY	$23.29 - $53.2 $809,583 - $1.85 Million	34,761 New	34,761 $1.18 Million

153

109M

153K

194K

Ticker ABCL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 285,139,008
Market Cap $787M
Description
AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...

Get notified when there are updates to the investment portfolio of Renaissance Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Renaissance Capital LLC with notifications on news.